8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-25-029639
Material agreement · Agreement ended
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading avtx-20250603.htm…